--- title: "This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday" type: "News" locale: "en" url: "https://longbridge.com/en/news/290195064.md" description: "Wall Street analysts initiated coverage on several stocks Thursday. Raymond James rated Terreno Realty (TRNO) Underperform. HC Wainwright gave Relmada Therapeutics (RLMD) a Buy with a $12 target. Goldman Sachs initiated Talen Energy (TLN) and Constellation Energy (CEG) with Buy and Neutral ratings, setting targets of $499 and $305 respectively. BofA Securities rated Immix Biopharma (IMMX) a Buy with a $27 target." datetime: "2026-06-18T11:45:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/290195064.md) - [en](https://longbridge.com/en/news/290195064.md) - [zh-HK](https://longbridge.com/zh-HK/news/290195064.md) generator: "portal-rs" --- # This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. - Raymond James analyst David Rodgers initiated coverage on **Terreno Realty Corp** (NYSE:TRNO) with an Underperform rating. Terreno Realty shares closed at $63.86 on Wednesday. See how other analysts view this stock. - HC Wainwright & Co. analyst Andres Y. Maldonado initiated coverage on **Relmada Therapeutics Inc** (NASDAQ:RLMD) with a Buy rating and announced a price target of $12. Relmada Therapeutics shares closed at $6.60 on Wednesday. See how other analysts view this stock. - Goldman Sachs analyst Carly Davenport initiated coverage on **Talen Energy Corp** (NASDAQ:TLN) with a Buy rating and announced a price target of $499. Talen Energy shares closed at $409.81 on Wednesday. See how other analysts view this stock. - B of A Securities analyst Tazeen Ahmad initiated coverage on **Immix Biopharma Inc** (NASDAQ:IMMX) with a Buy rating and announced a price target of $27. Immix Biopharma shares closed at $9.13 on Wednesday. See how other analysts view this stock. - Goldman Sachs analyst Carly Davenport initiated coverage on **Constellation Energy Corp** (NASDAQ:CEG) with a Neutral rating and announced a price target of $305. Constellation Energy shares closed at $267.17 on Wednesday. See how other analysts view this stock. Considering buying TLN stock? Here’s what analysts think: *Photo via Shutterstock* ### Related Stocks - [IMMX.US](https://longbridge.com/en/quote/IMMX.US.md) - [TRNO.US](https://longbridge.com/en/quote/TRNO.US.md) - [TLN.US](https://longbridge.com/en/quote/TLN.US.md) - [RLMD.US](https://longbridge.com/en/quote/RLMD.US.md) - [CEG.US](https://longbridge.com/en/quote/CEG.US.md) - [CEGX.US](https://longbridge.com/en/quote/CEGX.US.md) - [RJF.US](https://longbridge.com/en/quote/RJF.US.md) - [GS.US](https://longbridge.com/en/quote/GS.US.md) - [BAC.US](https://longbridge.com/en/quote/BAC.US.md) - [RJF-B.US](https://longbridge.com/en/quote/RJF-B.US.md) - [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md) - [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md) - [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md) - [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md) - [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md) - [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md) - [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md) - [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md) - [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md) - [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md) - [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md) - [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md) - [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md) - [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md) - [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md) - [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md) - [8648.JP](https://longbridge.com/en/quote/8648.JP.md) ## Related News & Research - [Relmada publishes investor presentation highlighting NDV-01 program for non-muscle invasive bladder cancer](https://longbridge.com/en/news/295148682.md) - [Terreno Realty Corporation (NYSE:TRNO) Given Consensus Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/en/news/297133508.md) - [Immix Biopharma highlights NXC-201 CAR-T data in relapsed/refractory AL amyloidosis trial presentation](https://longbridge.com/en/news/297810101.md) - [Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Securities Class Action](https://longbridge.com/en/news/297971037.md) - [Karyopharm grants 1,850 inducement RSUs to two new hires](https://longbridge.com/en/news/297692005.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**